Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive analysis of PD-L1 expression in glioblastoma multiforme.

Oncotarget - 27 Jun 2017

Heiland Dieter Henrik, Haaker Gerrit, Delev Daniel, Mercas Bianca, Masalha Waseem, Heynckes Sabrina, Gäbelein Annette, Pfeifer Dietmar, Carro Maria Stella, Weyerbrock Astrid, Prinz Marco, Schnell Oliver

Abstract excerpt

Glioblastoma multiforme are highly malignant brain tumours with frequent genetic and epigenetic alterations. The poor clinical outcome of these tumours necessitates the development of new treatment options. Immunotherapies for glioblastoma multiforme including PD1/PD-L1 inhibition are currently tested in ongoing clinical trials. The purpose of this study was to investigate the molecular background of PD-L1...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B7-H1 Antigen
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Regulatory Networks

Share to Glioblastoma

Share to Immunomodulation

Share to Neoplasm Grading

Share to Proteome

Share to Proteomics

Source

Open in PubMed Open full text

Identifiers

PMID: 28178682
DOI: 10.18632/oncotarget.15031
PMCID: PMC5522061

Genes

IDH1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive analysis of PD-L1 expression in glioblastoma multiforme.PMID 28178682Read ↗

Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain gliomaSemantic proximity Read ↗

Integrated analysis of programmed cell death ligand 1 expression reveals increased levels in high-grade gliomaSemantic proximity Read ↗

Regulation of PD1 signaling is associated with prognosis in glioblastoma multiformeSemantic proximity Read ↗

A Radiosensitivity Gene Signature and PD-L1 Status Predict Clinical Outcome of Patients with Glioblastoma Multiforme in The Cancer Genome Atlas DatasetSemantic proximity Read ↗

Immune checkpoint expression and therapeutic implications in IDH1-mutant and wild-type glioblastomas.Semantic proximity Read ↗

Regulatory Network of PD1 Signaling Is Associated with Prognosis in Glioblastoma Multiforme.Semantic proximity Read ↗

EGFR mutation: a prognostic factor associated with immune infiltration in lower-grade glioma.Semantic proximity Read ↗

Expression of programmed cell death-ligand 1 and its correlation with clinical outcomes in gliomasSemantic proximity Read ↗

Complex regulatory network of programmed death-ligand 1 in cancer: Cancer immunomodulation from molecular mechanisms to clinical applicationsSemantic proximity Read ↗

EGFR mutation: novel prognostic factor associated with immune infiltration in lower-grade glioma; an exploratory study.Semantic proximity Read ↗

PD-L1-related LncRNAs are Associated with Immune Microenvironment and Prognosis in GliomaSemantic proximity Read ↗

LRRFIP1, an epigenetically regulated gene, is a prognostic biomarker and predicts malignant phenotypes of glioma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.